⚖️ Factors Modifying Drug Action & Drug Interactions

By Dr. Sk Sabir Rahaman, MBBS, MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD 

📍 Specialist Family Physician | Consultant Pharmacologist | Lifestyle & Diabetes Expert

 One of the most fascinating aspects of pharmacology is that the same drug does not always act the same way in every person. Drug responses may vary in intensity (quantitative variation) or even in nature (qualitative variation).

This variability arises from a combination of drug-related and patient-related factors. Additionally, when multiple drugs are prescribed together, drug interactions can further modify therapeutic outcomes.

Let’s break this down systematically.

---

🧪 I. Drug-Related Factors

1. Route of Administration

• Quantitative variation: Dose and onset differ with route.

  • Example: IV morphine (5–10 mg) works faster and at lower doses than oral morphine (30–60 mg).

• Qualitative variation: Same drug may act differently via different routes.

  • Example: Magnesium sulfate → oral (purgative), IV (CNS depressant), topical (anti-inflammatory).

---

2. Presence of Other Drugs

Drug–drug interactions may produce:

• Additive (A + B = effect of A + B)

• Synergistic (A + B > effect of A + B)

• Potentiating (one enhances the other’s action)

• Antagonistic (one blocks the other’s action)

🔑 Example:

• Levodopa + Carbidopa → potentiation

• Naloxone + Morphine → antagonism

---

3. Cumulation

When drugs are eliminated slowly, repeated doses may lead to toxic build-up.

• Examples: Digoxin, chloroquine, emetine

---

👤 II. Patient-Related Factors

1. Age

• Neonates: Immature liver/kidney → slow metabolism/excretion

  • Chloramphenicol → Grey baby syndrome

• Elderly: Reduced organ function → ↑ drug accumulation

  • Aminoglycosides → dose reduction needed

📌 Pediatric dosing formulas:

• Young’s formula:
  Child dose = (Age / (Age + 12)) × Adult dose

• Dilling’s formula:
  Child dose = (Age / 20) × Adult dose

---

2. Body Weight & Body Surface Area (BSA)

• Weight-based dosing:
  Dose = (Patient’s weight / 70) × Adult dose

• BSA-based dosing (more accurate):
  Dose = (BSA / 1.73) × Adult dose

🧮 Mosteller’s formula:
BSA (m²) = √[(Height in cm × Weight in kg) / 3600]

---

3. Sex

• Hormonal differences influence drug metabolism and ADRs.

  • Example: β-blockers and diuretics → ↓ libido in males

---

4. Diet & Environment

• Food–drug interactions:

  • Milk ↓ tetracycline absorption

  • Fatty meals ↑ griseofulvin absorption

• Smoking: Induces CYP450 → ↑ metabolism of drugs like theophylline

---

5. Genetic Factors (Pharmacogenetics)

• Isoniazid: Fast vs slow acetylators

• Primaquine: Hemolysis in G6PD deficiency

• Succinylcholine: Prolonged apnea (pseudocholinesterase deficiency)

• CYP2C9 polymorphism: ↑ bleeding risk with warfarin

💡 Clinical pearl: Genetic screening = personalized therapy

---

6. Psychological Factors (Placebo Effect)

• Inert substances may produce real therapeutic benefit due to expectation and belief.

  • Example: Sugar pills relieving pain/anxiety

---

7. Pathological States

Condition	Impact on Drug Action
GI disorders	↓ absorption (e.g., achlorhydria, malabsorption)
Liver disease	↓ metabolism → ↑ bioavailability (e.g., propranolol)
Renal failure	↓ clearance → accumulation (e.g., aminoglycosides)
Iron deficiency anemia	↑ iron absorption from gut

---

8. Tolerance

• Natural: Genetic (e.g., rabbits tolerate atropine)

• Acquired: Repeated use → higher dose needed (morphine, nitrates)

• Cross-tolerance: Between similar drugs (morphine ↔ codeine)

• Tachyphylaxis: Rapid tolerance with repeated short doses (ephedrine, tyramine)

Mechanisms:

• Pharmacokinetic: ↑ metabolism (e.g., rifampin)

• Pharmacodynamic: ↓ receptor sensitivity (e.g., morphine)

---

9. Drug Dependence

• Psychological: Emotional stability depends on drug (e.g., cocaine, nicotine)

• Physical: Withdrawal syndrome if stopped (e.g., opioids, alcohol)

---

📊 Summary Table: Factors Modifying Drug Action

Factor	Example	Clinical Impact
Route	IV vs oral morphine	Alters dose & onset
Age	Chloramphenicol in neonates	Grey baby syndrome
Genetics	G6PD deficiency	Hemolysis with primaquine
Environment	Smoking	↑ drug metabolism
Psychological	Placebo	Symptom relief
Pathological	Liver/kidney disease	↑ toxicity risk
Tolerance	Morphine, nitrates	Higher doses needed
Dependence	Alcohol, opioids	Withdrawal syndrome

---

🔄 Drug Interactions

When multiple drugs are taken together, they may enhance, reduce, or alter each other’s effects.

• Beneficial: Synergy (e.g., levodopa + carbidopa)

• Harmful: Toxicity or therapeutic failure (e.g., warfarin + aspirin)

---

1. Pharmaceutical Interactions (In Vitro)

• Occur outside the body (IV fluids, syringes).

• Examples:

  • Phenytoin precipitates in dextrose solution

  • Ampicillin unstable in dextrose

  • Gentamicin + carbenicillin → ↓ gentamicin activity

💡 Tip: Always check IV compatibility charts.

---

2. Pharmacokinetic Interactions (In Vivo)

a. Absorption

• Antacids/iron/calcium ↓ tetracycline absorption

• Metoclopramide ↑ aspirin absorption

b. Distribution

• Protein-binding displacement → toxicity

  • Example: Salicylates displace warfarin → ↑ bleeding

c. Metabolism

• Enzyme induction: Carbamazepine → ↓ warfarin effect

• Enzyme inhibition: Erythromycin → ↑ carbamazepine toxicity

d. Excretion

• Probenecid ↓ penicillin excretion → prolonged action

• Salicylates ↓ methotrexate excretion → toxicity

---

3. Pharmacodynamic Interactions (In Vivo)

Type	Mechanism	Example	Effect
Additive	Sum of effects	Alcohol + benzodiazepines	CNS depression
Synergistic	> sum of effects	Trimethoprim + sulfamethoxazole	Antibacterial synergy
Antagonistic	One blocks the other	Naloxone + morphine	Opioid overdose reversal

---

📝 Final Takeaway

Drug action is never one-size-fits-all. It depends on:

• The drug itself (route, interactions, metabolism)

• The patient (age, genetics, environment, psychology, pathology)

💡 Understanding factors modifying drug action and drug interactions ensures:

• Safer prescribing

• Better therapeutic outcomes

• Fewer adverse effects